Crossmark

Carvedilol versus flecainide treatment in idiopathic ventricular extrasystoles and tachycardias (CARFLECT IV) trial: Rationale and design

Crossref DOI link: https://doi.org/10.1016/j.repc.2025.07.004

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Trincado Ave, Mauro

Brión, María

Díaz Fernández, Brais

Blanco-Verea, Alejandro

Cabaleiro Ocampo, Teresa

Estany Gestal, Ana

Tilves, Carlos

Moure González, María

Seoane Blanco, Ana

García-Rodeja, Federico

González-Juanatey, José Ramón

Rodríguez Mañero, Moisés
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01

Version of Record valid from 2025-10-17
More Information

This article is maintained by: Elsevier

Article Title: Carvedilol versus flecainide treatment in idiopathic ventricular extrasystoles and tachycardias (CARFLECT IV) trial: Rationale and design

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2025.07.004

Content Type: article

Copyright: © 2025 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.